A PHASE-II TRIAL OF VINBLASTINE, BLEOMYCIN, AND CISPLATIN INDUCTION FOLLOWED BY DACARBAZINE AND DIBROMODULCITOL MAINTENANCE IN THE TREATMENT OF METASTATIC MELANOMA - A FOLLOW-UP-STUDY OF 22 PATIENTS

被引:3
作者
GENTILE, PS
EPREMIAN, BE
SEEGER, J
HAMM, JT
SHETH, SP
机构
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1988年 / 11卷 / 06期
关键词
D O I
10.1097/00000421-198812000-00016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:666 / 668
页数:3
相关论文
共 12 条
[1]  
BAJETTA E, 1982, CANCER TREAT REP, V66, P1299
[2]  
BELLET RE, 1978, CANCER TREAT REP, V62, P2095
[3]  
COWDAN DH, 1971, CANCER CHEMOTHER REP, V55, P175
[4]  
CREAGAN ET, 1981, CANC TREAT REP, V66, P567
[5]   WR-2721 AND HIGH-DOSE CISPLATIN - AN ACTIVE COMBINATION IN THE TREATMENT OF METASTATIC MELANOMA [J].
GLOVER, D ;
GLICK, JH ;
WEILER, C ;
FOX, K ;
GUERRY, D .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (04) :574-578
[6]  
JOHNSON DH, 1985, CANCER TREAT REP, V69, P821
[7]  
NATHANSON L, 1981, CANCER-AM CANCER SOC, V48, P1290, DOI 10.1002/1097-0142(19810915)48:6<1290::AID-CNCR2820480605>3.0.CO
[8]  
2-1
[9]  
RICHMAN SP, 1984, CANCER TREAT REP, V68, P1395
[10]  
ROSENBERG SA, 1987, NEW ENGL J MED, V316, P799